Figure S1 from Preclinical Development of MGC028, an ADAM9-Targeted, Glycan-Linked, Exatecan-Based Antibody–Drug Conjugate for the Treatment of Solid Cancers
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
Monoclonal and Polyclonal Antibodies Research
Toxin Mechanisms and Immunotoxins
Protein Degradation and Inhibitors
Publication details
- Publication date
- 2 April 2026
- Language
- EN